======= LPIN2 =======
== Gene Information ==
* **Official Symbol**: LPIN2
* **Official Name**: lipin 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9663|9663]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q92539|Q92539]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=LPIN2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LPIN2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605519|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: Mouse studies suggest that this gene functions during normal adipose tissue development and may play a role in human triglyceride metabolism. This gene represents a candidate gene for human lipodystrophy, characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Plays important roles in controlling the metabolism of fatty acids at different levels. Acts as a magnesium-dependent phosphatidate phosphatase enzyme which catalyzes the conversion of phosphatidic acid to diacylglycerol during triglyceride, phosphatidylcholine and phosphatidylethanolamine biosynthesis in the reticulum endoplasmic membrane. Acts also as a nuclear transcriptional coactivator for PPARGC1A to modulate lipid metabolism (By similarity). {ECO:0000250}.
|Lipin N|
|LNS2|
|phosphatidate phosphatase activity|
|phosphatidylethanolamine biosynthetic process|
|triglyceride biosynthetic process|
|acylglycerol biosynthetic process|
|neutral lipid biosynthetic process|
|phosphatidylethanolamine metabolic process|
|phosphatidylcholine biosynthetic process|
|triglyceride metabolic process|
|phosphatidylcholine metabolic process|
|fatty acid catabolic process|
|acylglycerol metabolic process|
|neutral lipid metabolic process|
|monocarboxylic acid catabolic process|
|cellular response to insulin stimulus|
|ammonium ion metabolic process|
|cellular lipid catabolic process|
|glycerophospholipid biosynthetic process|
|glycerolipid biosynthetic process|
|response to insulin|
|phospholipid biosynthetic process|
|organic acid catabolic process|
|carboxylic acid catabolic process|
|cellular response to peptide hormone stimulus|
|transcription coactivator activity|
|lipid catabolic process|
|glycerophospholipid metabolic process|
|dephosphorylation|
|fatty acid metabolic process|
|cellular response to peptide|
|phospholipid metabolic process|
|glycerolipid metabolic process|
|response to peptide hormone|
|small molecule catabolic process|
|response to peptide|
|monocarboxylic acid metabolic process|
|organophosphate biosynthetic process|
|lipid biosynthetic process|
|cellular response to organonitrogen compound|
|cellular response to hormone stimulus|
|cellular response to nitrogen compound|
|organophosphate metabolic process|
|response to hormone|
|carboxylic acid metabolic process|
|endoplasmic reticulum membrane|
|cellular lipid metabolic process|
|response to organonitrogen compound|
|oxoacid metabolic process|
|organic acid metabolic process|
|cellular response to oxygen-containing compound|
|response to nitrogen compound|
|lipid metabolic process|
|positive regulation of transcription by RNA polymerase II|
|cellular response to endogenous stimulus|
|organonitrogen compound biosynthetic process|
|response to endogenous stimulus|
|positive regulation of transcription, DNA-templated|
|response to oxygen-containing compound|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of RNA metabolic process|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 10976
* **Expression level (log2 read counts)**: 6.11
{{:chemogenomics:nalm6 dist.png?nolink |}}